12 In Peru, preliminary results from two sero prevalence studies have been reported: one study done in July, 2020, reported a seroprevalence of 29•7% in the region of Lambayeque; 13 and another done in December, 2020, found a seroprevalence of 39•3% in the regions of Lima and Callao using population-based sampling techniques.